Snapshot
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
The global Eosinophilic Esophagitis Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Eosinophilic Esophagitis Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Budesonide
Fluticasone
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Shire
Calypso
Celgene
Regeneron
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Drugstore
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Eosinophilic Esophagitis Drug Industry
Figure Eosinophilic Esophagitis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Eosinophilic Esophagitis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Eosinophilic Esophagitis Drug
1.2.2 Downstream
Table Application Segment of Eosinophilic Esophagitis Drug
Table Global Eosinophilic Esophagitis Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Eosinophilic Esophagitis Drug Market by Type
3.1 By Type
3.1.1 Budesonide
Table Major Company List of Budesonide
3.1.2 Fluticasone
Table Major Company List of Fluticasone
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Eosinophilic Esophagitis Drug Market 2016-2020, by Type, in USD Million
Figure Global Eosinophilic Esophagitis Drug Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Eosinophilic Esophagitis Drug Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 AstraZeneca (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.1.2 AstraZeneca Products & Services
4.1.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GSK (Company Profile, Sales Data etc.)
4.2.1 GSK Profile
Table GSK Overview List
4.2.2 GSK Products & Services
4.2.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Adare Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Adare Pharmaceuticals Profile
Table Adare Pharmaceuticals Overview List
4.4.2 Adare Pharmaceuticals Products & Services
4.4.3 Adare Pharmaceuticals Business Operation Conditions
Table Business Operation of Adare Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 DBV Technologies (Company Profile, Sales Data etc.)
4.5.1 DBV Technologies Profile
Table DBV Technologies Overview List
4.5.2 DBV Technologies Products & Services
4.5.3 DBV Technologies Business Operation Conditions
Table Business Operation of DBV Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dr. Falk Pharma (Company Profile, Sales Data etc.)
4.6.1 Dr. Falk Pharma Profile
Table Dr. Falk Pharma Overview List
4.6.2 Dr. Falk Pharma Products & Services
4.6.3 Dr. Falk Pharma Business Operation Conditions
Table Business Operation of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Quorum Innovations (Company Profile, Sales Data etc.)
4.7.1 Quorum Innovations Profile
Table Quorum Innovations Overview List
4.7.2 Quorum Innovations Products & Services
4.7.3 Quorum Innovations Business Operation Conditions
Table Business Operation of Quorum Innovations (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Shire (Company Profile, Sales Data etc.)
4.8.1 Shire Profile
Table Shire Overview List
4.8.2 Shire Products & Services
4.8.3 Shire Business Operation Conditions
Table Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Calypso (Company Profile, Sales Data etc.)
4.9.1 Calypso Profile
Table Calypso Overview List
4.9.2 Calypso Products & Services
4.9.3 Calypso Business Operation Conditions
Table Business Operation of Calypso (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Celgene (Company Profile, Sales Data etc.)
4.10.1 Celgene Profile
Table Celgene Overview List
4.10.2 Celgene Products & Services
4.10.3 Celgene Business Operation Conditions
Table Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Regeneron (Company Profile, Sales Data etc.)
4.11.1 Regeneron Profile
Table Regeneron Overview List
4.11.2 Regeneron Products & Services
4.11.3 Regeneron Business Operation Conditions
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Eosinophilic Esophagitis Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Eosinophilic Esophagitis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Eosinophilic Esophagitis Drug Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Eosinophilic Esophagitis Drug Market Concentration, in 2020
Figure Europe Eosinophilic Esophagitis Drug Market Market Concentration, in 2020
Figure Asia-Pacific Eosinophilic Esophagitis Drug MMarket Concentration, in 2020
Figure South America Eosinophilic Esophagitis Drug Market Concentration, in 2020
Figure Middle East & Africa Eosinophilic Esophagitis Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Eosinophilic Esophagitis Drug Demand in Hospitals, 2016-2020, in USD Million
6.1.2 Demand in Clinics
Figure Eosinophilic Esophagitis Drug Demand in Clinics, 2016-2020, in USD Million
6.1.3 Demand in Drugstore
Figure Eosinophilic Esophagitis Drug Demand in Drugstore, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Eosinophilic Esophagitis Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Eosinophilic Esophagitis Drug Market Growth 2021-2026, by Application, in USD Million
Figure Eosinophilic Esophagitis Drug Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Eosinophilic Esophagitis Drug Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Eosinophilic Esophagitis Drug Market 2016-2020, by Region, in USD Million
Table Global Eosinophilic Esophagitis Drug Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Eosinophilic Esophagitis Drug Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Eosinophilic Esophagitis Drug Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Eosinophilic Esophagitis Drug Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Eosinophilic Esophagitis Drug Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Eosinophilic Esophagitis Drug Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Eosinophilic Esophagitis Drug Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Eosinophilic Esophagitis Drug Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Eosinophilic Esophagitis Drug Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Eosinophilic Esophagitis Drug Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Eosinophilic Esophagitis Drug Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Eosinophilic Esophagitis Drug Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion